You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 8, August 27, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Journalology/ Peer Review/ Authorship
 •Medical Practice
 •Medical Ethics
 •Neurology
 •Alzheimer Disease
 •Cognitive Disorders
 •Statistics and Research Methods
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Drs FitzGerald, Patrono, and Hawkey write that review papers they authored were inappropriately included in the Table in our article, explaining that their articles were independently authored without discussion of their content with Merck before publication. The Table, as stated in its legend and in the text of the article, includes articles identified from internal documents,1-2 as well as other articles by investigators identified within internal documents. Articles by such investigators were found by searching MEDLINE, as we described. All of these articles were examined to better understand patterns of disclosure, as we believed that either their mention within internal documents or the mention of specific investigators suggested that Merck was aware of the publication and perhaps had provided support for the project. Correspondence with Merck, acknowledged by FitzGerald and Patrono, led to the identification of their articles using MEDLINE. To our knowledge, these articles were not discussed . . . [Full Text of this Article]

Joseph S. Ross, MD, MHS
joseph.ross@mssm.edu
Department of Geriatrics and Adult Development
Mount Sinai School of Medicine
New York, New York

David S. Egilman, MD, MPH
Department of Community Health
Brown University School of Medicine
Providence, Rhode Island

Harlan M. Krumholz, MD, SM
Department of Medicine
Yale University School of Medicine
New Haven, Connecticut



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
and
JAMA. ;300():900-900.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():900-901.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():901-901.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():901-901.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
, , and
JAMA. ;300():901-902.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():902-902.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():902-903.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():903-903.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
and
JAMA. ;300():903-904.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
and
JAMA. ;300():904-904.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
and
JAMA. ;300():904-904.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
and
JAMA. ;300():905-906.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Conflicts of Interest, Authorship, and Disclosures in Industry-Related Scientific Publications: The Tort Bar and Editorial Oversight of Medical Journals
Hirsch
Mayo Clin Proc. 2009;84:811-821.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.